Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1983-4-7
pubmed:abstractText
Hepatocyte phosphatidylinositol 4,5-bisphosphate (4,5-P2), phosphatidylinositol 4-phosphate (4-P), and phosphatidylinositol were labeled with 3H when rats were injected intraperitoneally with 200 microCi of [2-3H] myo-inositol 18 h previously. Phosphatidylinositol 4,5-P2 and phosphatidylinositol 4-P accounted for 0.84 +/- 0.06 and 7.48 +/- 0.36%, respectively, of the total [3H] myo-inositol containing phospholipids. The breakdown of phosphatidylinositol 4,5-P2 was stimulated transiently (maximum effect seen at 15 s) and in a Ca2+-dependent manner by 10(-8) M vasopressin. Phosphatidylinositol 4-P breakdown was enhanced to a smaller, but longer, extent by vasopressin, whereas no changes in phosphatidylinositol were detected up to 120 s. Subcellular fractionation studies also showed no preferential breakdown of phosphatidylinositol in plasma membranes at 5-20 min. Only doses of vasopressin (10(-8) and 10(-7) M) in excess of those producing maximum effects on phosphorylase activation and Ca2+ efflux (10(-9) M) were effective at stimulating phosphatidylinositol 4,5-P2 breakdown. It is concluded that phosphatidylinositol 4,5-P2 breakdown induced by vasopressin in rat hepatocytes is not responsible for the mobilization of Ca2+ which leads to the activation of phosphorylase. On the contrary, it is Ca2+-dependent and appears to require the occupation of more receptors than are required for Ca2+ mobilization and phosphorylase activation.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
258
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2770-3
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis in hepatocytes by vasopressin.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S.